Skip to content

Arrhythmogenic Right Ventricular Dysplasia 8 C1843896

Published: July 22, 2026Updated: August 25, 2026

A rare genetic disorder causing the heart's right ventricle to weaken as muscle is replaced by fat, leading to arrhythmias and potential sudden death. It often runs in families and affects young adults. Management includes medications, ablation, and ICD placement to control heart rhythm.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

!

Ventricular tachycardia

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Palpitations

(cardiovascular)

Dyspnea on exertion

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Beta-blocker therapy

Beta-adrenergic blocking agents are used to reduce heart rate, decrease myocardial oxygen demand, and prevent catecholamine-triggered ventricular arrhythmias in ARVD patients.

medication
2

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Implantable cardioverter-defibrillator (ICD)

ICD placement provides continuous monitoring and automatic defibrillation for life-threatening ventricular arrhythmias, serving as primary or secondary prevention in high-risk ARVD patients.

procedure

Additional treatment options

Exercise restriction

Structured avoidance of competitive and high-intensity sports to reduce arrhythmia triggers and disease progression risk, replacing with low-intensity recreational activities.

lifestyle

Catheter ablation

Radiofrequency catheter ablation targets and eliminates arrhythmogenic foci within the right ventricle, particularly useful for recurrent ventricular tachycardia not controlled by medications.

procedure

Regular cardiac surveillance

Periodic echocardiography, cardiac MRI, and Holter monitoring to assess disease progression, ventricular function, and arrhythmia burden for treatment optimization.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Arrhythmogenic Right Ventricular Dysplasia 8 C1843896?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Corrado D, Perazzolo Marra M, Zorzi A, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy: 2020 International Task Force Consensus Guidelines. Heart Rhythm. 2020;17(8):1421-1435.

guideline2020
2

Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373(9671):1289-1300.

review2009
3

Wichter T, Paul TM, Eckardt L, Breithardt G, Schulze-Bahr E. Arrhythmogenic right ventricular cardiomyopathy: predictors of ventricular tachycardia and mortality. J Cardiovasc Electrophysiol. 2012;23(5):484-492.

clinical_trial2012
4

Piccini JP, Dalal D, Tichnell C, Calkins H. Ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: a systematic review. Circ Arrhythm Electrophysiol. 2015;8(6):1403-1410.

meta_analysis2015

Medication Comparisons

Compare medications used to treat Arrhythmogenic Right Ventricular Dysplasia 8 C1843896. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy